|
(4Z,7Z,10Z,12E,14R,16Z,19Z)- 14,22- dihydroxydocosahexaenoic acid |
|
CHEBI:137350 |
|
(4Z,7Z,10Z,12E,14R,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid |
|
A dihydroxydocosahexaenoic acid that is (4Z,7Z,10Z,12E,16Z,19Z)-docosahexaenoic acid in which the two hydroxy substituents are located at the 14R- and 22-positions. |
|
 
This entity has been manually annotated by the ChEBI Team.
|
|
Bijay
|
|
CHEBI:140255
|
|
ZINC000030729497 |
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C22H32O4/c23- 20- 16- 12- 8- 7- 10- 14- 18- 21(24) 17- 13- 9- 5- 3- 1- 2- 4- 6- 11- 15- 19- 22(25) 26/h1- 2,5- 6,8- 14,17,21,23- 24H,3- 4,7,15- 16,18- 20H2,(H,25,26) /b2- 1- ,9- 5- ,11- 6- ,12- 8- ,14- 10- ,17- 13+/t21- /m0/s1 |
OIAXNIJCPGIEPH-LSBIKEGXSA-N |
C(C(O)=O)C/C=C\C/C=C\C/C=C\C=C\[C@@H](C/C=C\C/C=C\CCO)O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
|
|
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
|
|
View more via ChEBI Ontology
Outgoing
|
(4Z,7Z,10Z,12E,14R,16Z,19Z)- 14,22- dihydroxydocosahexaenoic acid
(CHEBI:137350)
has role
anti-inflammatory agent
(CHEBI:67079)
(4Z,7Z,10Z,12E,14R,16Z,19Z)- 14,22- dihydroxydocosahexaenoic acid
(CHEBI:137350)
has role
human xenobiotic metabolite
(CHEBI:76967)
(4Z,7Z,10Z,12E,14R,16Z,19Z)- 14,22- dihydroxydocosahexaenoic acid
(CHEBI:137350)
is a
ω-hydroxy-long-chain fatty acid
(CHEBI:140997)
(4Z,7Z,10Z,12E,14R,16Z,19Z)- 14,22- dihydroxydocosahexaenoic acid
(CHEBI:137350)
is a
dihydroxydocosahexaenoic acid
(CHEBI:137348)
(4Z,7Z,10Z,12E,14R,16Z,19Z)- 14,22- dihydroxydocosahexaenoic acid
(CHEBI:137350)
is a
secondary allylic alcohol
(CHEBI:134396)
(4Z,7Z,10Z,12E,14R,16Z,19Z)- 14,22- dihydroxydocosahexaenoic acid
(CHEBI:137350)
is conjugate acid of
(4Z,7Z,10Z,12E,14R,16Z,19Z)-14,22-dihydroxydocosahexaenoate
(CHEBI:136530)
(4Z,7Z,10Z,12E,14R,16Z,19Z)- 14,22- dihydroxydocosahexaenoic acid
(CHEBI:137350)
is enantiomer of
(4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid
(CHEBI:137349)
|
|
Incoming
|
(4Z,7Z,10Z,12E,14R,16Z,19Z)-14,22-dihydroxydocosahexaenoate
(CHEBI:136530)
is conjugate base of
(4Z,7Z,10Z,12E,14R,16Z,19Z)- 14,22- dihydroxydocosahexaenoic acid
(CHEBI:137350)
(4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid
(CHEBI:137349)
is enantiomer of
(4Z,7Z,10Z,12E,14R,16Z,19Z)- 14,22- dihydroxydocosahexaenoic acid
(CHEBI:137350)
|
(4Z,7Z,10Z,12E,14R,16Z,19Z)- 14,22- dihydroxydocosa- 4,7,10,12,16,19- hexaenoic acid
|
(14R,22)-diHDHA
|
ChEBI
|
(14R,22)-DiHDoHE
|
ChEBI
|
(14R,22)- dihydroxy- (4Z,7Z,10Z,12E,16Z,19Z)- docosahexaenoic acid
|
ChEBI
|
14(R),22-diHDHA
|
SUBMITTER
|
14(R),22-dihydroxydocosahexaenoic acid
|
ChEBI
|
MaR-L2
|
SUBMITTER
|
maresin-L2
|
ChEBI
|
27627500
|
Reaxys Registry Number
|
Reaxys
|
25200603
|
PubMed citation
|
Europe PMC
|
|